ProThera Biologics
Biotechnology Research • 
East Providence, Rhode Island, United States • 1-10 Employees
Company overview
| Headquarters | 551 Warren Ave, East Providence, Rhode Island 02914, US |
| Phone number | +14013012046 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Employees | 1-10 |
| Socials |
Key Contact at ProThera Biologics
Richard Andrews
Director
About ProThera Biologics
ProThera Biologics is a company that develops a fundamentally new paradigm for treating severe inflammation. They are developing a class of human plasma proteins that evolved to control inflammation by modulating multiple pathways to restore patients health. Their approach involves developing inter-alpha inhibitor proteins that are essential for human health and are known for their potential to treat patients with severe inflammatory diseases.
ProThera Biologics revenue & valuation
| Annual revenue | $10,000,000 |
| Revenue per employee | $2,000,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $32,000,000 |
| Total funding | $750,000 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
ProThera Biologics Tech Stack
Discover the technologies and tools that power ProThera Biologics's digital infrastructure, from frameworks to analytics platforms.
Web servers
Programming languages
Blogs
Hosting
Databases
United Kingdom
Netherlands
Canada
South AfricaFrequently asked questions
4.8
40,000 users
